Electrome Bioelectric Therapeutics Platform being used to explore inhibition of pathogen motility and persistence, with implications for infectious ...

Electrome Corporation, a unique biotech company developing next-generation bioelectric therapeutics, today announced the launch of the LymeCure Research Study, a collaborative research effort with ...

Every night, millions of people work hard to keep our essential services running—treating patients, responding to emergencies ...

Increased esophageal hypervigilance and anxiety were associated with worse post-treatment symptoms and poor quality of life ...

BACKGROUND: The high-resolution manometry has been a significant advance in esophageal diagnostics. There are different types of catheter and systems devices to capture esophageal pressures that ...

Infertility affects about one in six couples, and male factors account for roughly half of all cases-often because sperm don't swim well. Researchers from the University of Osaka uncovered a key ...

A ransomware attack at Motility Software Solutions, a provider of dealer management software (DMS), has exposed the sensitive data of 766,000 customers. Motility (formerly known as Systems 2000/Sys2K) ...

Background: Gastroesophageal reflux disease has a prevalence of 12% in the Brazilian population. Its treatment includes hygienic-dietary changes, use of medications and, in selected cases, surgery ...

Introduction Concurrent with infants’ progression in dietary complexity and gut microbiome diversity, infants gradually change their defecation patterns during the first year of life. However, the ...

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. The World Health Organization estimates that infertility impacts one in six adults globally. But when it comes to ...

The phase 3 IDeate-Esophageal01 study of ifinatamab deruxtecan has dosed its first patient with esophageal squamous cell carcinoma. The first patient in the phase 3 IDeate-Esophageal01 study ...